menu
    • menu

    Company profile for Flamingo Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our company was built upon our deep experience and know-how in RNA therapeutics and we are well-positioned to advance candidates against targets considered “undruggable”, using RNA chemistries. We are focused on advancing our clinical pipeline for large unmet oncology indications where we believe RNA-targeting can be successful.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Flamingo TherapeuticsBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Gaston Geenslaan 1 3001 Leuven
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://flamingotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/flamingo-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Flamingo Therapeutics Presents at AACR Special Cancer Conference
    Flamingo Therapeutics Presents at AACR Special Cancer Conference

    14 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-announces-oral-presentation-at-aacr-special-conference-in-cancer-research-on-rnas-as-drivers-targets-and-therapeutics-in-cancer-302305011.html

    PR NEWSWIRE
    14 Nov 2024
    Share Share
    Flamingo Highlights MALAT1 Inhibitor FLM-7523 At EACR 2024
    Flamingo Highlights MALAT1 Inhibitor FLM-7523 At EACR 2024

    10 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-announces-poster-presentation-at-eacr-2024-congress-on-flm-7523-ftx-001-a-first-in-class-inhibitor-of-the-long-non-coding-rna-malat1-302167874.html

    PR NEWSWIRE
    10 Jun 2024
    Share Share
    Flamingo Therapeutics Appoints Leading Medical Oncologist Ezra Cohen as MD
    Flamingo Therapeutics Appoints Leading Medical Oncologist Ezra Cohen as MD

    21 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-appoints-leading-medical-oncologist-ezra-cohen-md-to-its-board-of-directors-302095070.html

    PR NEWSWIRE
    21 Mar 2024
    Share Share
    Flamingo Announces Appointment of Andrew E. Denker, MD, PhD, as CMO
    Flamingo Announces Appointment of Andrew E. Denker, MD, PhD, as CMO

    04 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-announces-appointment-of-andrew-e-denker-md-phd-as-chief-medical-officer-301789459.html

    PR NEWSWIRE
    04 Apr 2023
    Share Share
    Flamingo Therapeutics and Dynacure Announce Merger
    Flamingo Therapeutics and Dynacure Announce Merger

    02 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-and-dynacure-announce-merger-to-create-leading-rna-therapeutics-company-focused-on-clinical-oncology-301760437.html

    PR NEWSWIRE
    02 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search